Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aiyu capsule for prevention and treatment of chemotherapy-related leukopenia
ChiCTR2200067058Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Guizhou University of Chinese Medicine
- Start
- Dec 2022
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of AiYu capsule in chemotherapy-induced leukopenia (CIL) and chemotherapy-induced neutropenia (CIN) (2 arms), sponsored by First Affiliated Hospital of Guizhou University of Chinese Medicine. Primary endpoint: Extent, incidence, and duration of leukopenia and neutrophil reduction after chemotherapy. Planned start Dec 2022; status: not yet recruiting.
02
Drugs
AiYu capsule
03
Conditions
chemotherapy-induced leukopenia (CIL)chemotherapy-induced neutropenia (CIN)
Beyond the preview
Go deeper on ChiCTR2200067058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200067058.